Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of the Safety and Antibody Responses of Plasma Donors Vaccinated With a Licensed Tdap Vaccine for a Hyperimmunization Program

NCT05662852 is registered in ClinicalTrials.gov with ABO Holdings, Inc. as lead sponsor.

NCT NCT05662852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05662852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of the Safety and Antibody Responses of Plasma Donors Vaccinated With a Licensed Tdap Vaccine for a Hyperimmunization Program
Lead sponsor
ABO Holdings, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 5, 2023
Completion date
May 12, 2025
Enrollment
107 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tetanus, diphtheria and acellular pertussis vaccination